BRCA1 and BRCA2 have a limited role in familial prostate cancer

Cancer Research

Volumn 60, Issue 5, 2000, Pages 1371-1375

  Sinclair, Colleen Schehl ^a   Berry, Rebecca ^a   Schaid, Daniel ^a   Thibodeau, Stephen N ^a   Couch, Fergus J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; FAMILIAL CANCER; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HIGH RISK POPULATION; HUMAN; INTRON; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; PROSTATE CANCER;

AGED; BRCA1 PROTEIN; BRCA2 PROTEIN; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 0034162984     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Thiessen, E. Concerning a familial association between breast cancer and both prostatic and uterine malignancies. Cancer (Phila.), 34: 1102-1107, 1974.
2. Anderson, D., and Badzioch, M. Breast cancer risks in relatives of male breast cancer patients. J. Natl. Cancer Inst., 84: 1114-1117, 1992.
3. Anderson, D., and Badzioch, M. Familial breast cancer risks. Effects of prostate and other cancers. Cancer (Phila.), 72: 114-119, 1993.
4. Tulinius, H., Egilsson, V., Olafsdottir, G., and Sigvaldason, H. Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer. Br. Med. J., 305: 855-857, 1992.
5. Sellers, T. A., Potter, J. D., Rich, S. S., Drinkard, C. R., Bostick, R. M., Kushi, L. H., Zheng, W., and Folsom, A. R. Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer. J. Natl. Cancer Inst., 86: 1860-1865, 1994.
6. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, A. P., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, M. L., Ding, W., Bell, R., Rosenthal, J., Hussey, C., Tran, T., McClure, M., Frye, C., Hattier, T., Phelps, R., Haugen-Strano, A.. Katcher, H., Yakumo, K., Gholami, Z., Shaffer, D., Stone, S., Bayer, S., Wray, C., Bogden, R., Dayananth, P., Ward, J., Tonin, P., Narod, S., Bristow, P. K., Norris, F. H., Helvering, L., Morrison, P., Rosteck, P., Lai, M., Barrett, J. C., Lewis, C., Neuhausen, S., Cannon-Albright, L., Goldgar, D., Wiseman, R., Kamb, A., and Skolnick, M. H. A strong candidate for the breast and ovarian cancer susceptibility gene. BRCA1. Science (Washington DC), 266: 66-71, 1994.
7. Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., and Micklem, G. Identification of the breast cancer susceptibility gene. BRCA2. Nature (Lond.), 378: 789-792, 1995.
8. Tavtigian, S. V., Simard, J., Rommens, J., Couch, F., Shattuck-Eidens, D., Neuhausen, S., Merajver, S., Thorlacius, S., Offit, K., Stoppa-Lyonnet, D., Belanger, C., Bell, R., Berry, S., Bogden, R., Chen, Q., Davis, T., Dumont, M., Frye, C., Hattier, T., Jammulapati, S., Janecki, T., Jiang, P., Kehrer, R., Leblanc, J. F., Milchell J. T., McArthur-Morrison, J., Nguyen, K., Peng, Y., Samson, C., Schroeder, M., Snyder, S. C., Steele, L., Stringfellow, M., Stroup, C. Swedlund, B., Swensen, J., Teng, D., Thomas, A., Tran, T., Tran, T., Trandnant, M., Weaver-Feldhaus, J., Wong, A. K. C., Shizuya, H., Eyfjord, J. E., Cannon-Albright, L., Labrie, F., Skolnick, M. H., Weber, B., Kamb, A., and Goldgar, D. E. The complete BKCA2 gene and mutations in 13q-linked kindreds. Nat. Genet., 12: 333-337, 1996.
9. Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., Bishop, D. T., Weber, B., Lenoir, G., Chang-Claude, J., Sobol, H., Teare, M. D., Struewing, J., Arason, A., Scherneck, S., Peto, J., Rebbeck, T. R., Tonin, P., Neuhausen, S., Barkardottir, R., Eyfjord, J., Lynch, H., Ponder, B. A., Gayther, S. A., Birch, J. M., Lindblom, A., Stoppa-Lyonnet, D., Bignon, Y., Borg, A., Hamann, U., Hailtes, N., Scott, R. J., Maugard, C. M., Vasen, H., Seitz, S., Cannon-Aibright, L. A., Schofield, A., Zelada-Hedman, M., and the Breast Cancer Linkage Consortium. Genetic heterogeneity and penetrance analysis of the BRCA1 and BKCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am. J. Hum. Genet., 62: 676-689, 1998.
10. Gudmundsson, J., Johannesdottir, G., Arason, A., Bergthorsson, J. T., Ingvarsson, S., Egilsson, V., and Barkardottir, R. B. Frequent occurrence of BKCA2 linkage in Icelandic breast cancer families and segregation of a common BRCA2 haplotype. Amer. J. Hum. Genet., 58: 749-756, 1996.
11. Thorlacius, S., Olafsdottir, G., Tryggvadottir, L., Neuhausen, S., Jonasson, J. G., Tavtigian, S. V., Tulinius, H., Ogmundsdottir, H. M., and Eyfjord, J. E. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat. Genet., 13: 117-119, 1996.
12. Katagiri, T., Nakamura, Y., and Miki, Y. Mutations in the BRCA2 gene in hepato-cellular carcinomas. Cancer Res., 56: 4575-4577, 1996.
13. The Breast Cancer Linkage Consortium. Cancer Risks in BKCA2 mutation carriers. J. Natl. Cancer Inst., 91: 1310-1316, 1999.
14. Goggins, M., Schutte, M., Lu, J., Moskaluk, C. A., Weinstien, C. L., Petersen, G. M., Yeo, C. J., Jackson, C. E., Lynch, H. T., Hruban, R. H., and Kern, S. E. Germline BKCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res., 56: 5360-5364, 1996.
15. Arason, A., Barkardottir, R., and Egilsson, V. Linkage analysis of chromosome 17q markers and breast-ovarian cancer in Icelandic families, and possible relationship to prostate cancer. Am. J. Hum. Genet., 52: 711-717, 1993.
16. Ford, D., Easton, D., Bishop, D., Narod, S., Goldgar, D., the Breast Cancer Linkage Consortium. Risks of cancer in BRCA1-mutation carriers. Lancet. 343: 692-695, 1994.
17. Easton, D. F., Steele, L., Fields, P., Ormiston, W., Averill, D., Daly, P. A., McManus, R., Neuhausen, S. L., Ford, D., Wooster, R., Cannon-Albright, L. A., Stratton, M. R., and Goldgar, D. E. Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am. J. Hum. Genet., 61: 120-128, 1997.
18. Langsten, A. A., Stanford, J. L., Wicklund, K. G., Thompson, J. D., Blazej, R. G., and Ostrander, E. A. Germ-Line BRCA1 mutations in selected men with prostate cancer. Am. J. Hum. Genet., 58: 881-885, 1996.
19. Uchida, T., Wang, C., Sato, T., Gao, J., Takashima, R., Irie, A., Ohori, M., and Koshiba, K. BRCA1 gene mutation and loss of heterozygosity on chromosome 17q21 in primary prostate cancer. Int. J. Cancer. 84: 19-23, 1999.
20. Edwards, S. M., Dunsmuir, W. D., Gillett, C. E., Lakhani, S. R., Corbishley, C., Young, M., Kirby, R. S., Dearnaley, D. P., Dowe, A., Ardern-Jones, A., Kelly, J., CRC/BPG UK Familial Prostate Cancer Study Collaborators, Spurr. N., Barnes, D. M., and Eeles, R. A. Immunohistochemical expression of BRCA2 protein and allelic loss at the BRCA2 locus in prostate cancer. Int. J. Cancer, 78: 1-7, 1998.
21. Struewing, J. P., Abeliovich, D., Peretz, T., Avishai, N., Kaback, M. M., Collins, F. S., and Brody, L. C. The carrier frequency of the BRCA1 185delAG mutations is approximately 1% in Ashkenazi Jewish individuals. Nat. Genet., 11: 198-200, 1995.
22. Oddoux, C., Struewing, J. P., Clayton, C. M., Neuhausen, S., Brody, L. C., Kaback, M., Haas, B., Norton, L., Borgen, P., Jhanwar, S., Goldgar, D., Ostrer, H., and Offit, K. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat. Genet., 14: 188-190, 1996.
23. Lehrer, S., Fodor, F., Stock, R., Stone, N. N., Eng, C., Song, H. K., and McGovern, M. Absence of 185delAG mutation of the BACA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer. Br. J. Cancer. 78: 771-773, 1998.
24. Wilkens, E. P., Freije, D., Xu, J., Nusskern, D. R., Suzuki, H., Isaacs, D. S., Wiley, K., Bujnovszky, P., Meyers, D. A., Walsh, P. C., and Isaacs, W. B. No evidence for a role of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with hereditary prostate cancer. Prostate, 39: 280-284, 1999.
25. Nastiuk, K. L., Mansukhani, M., Terry, M. B., Kularatne, P., Rubin, M. A., Melamed, J., Gammon, M. D., Ittmann, M., and Krolewski, J. J. Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men. Prostate, 40: 172-177, 1999.
26. Johannesdottir, G., Gudmundsson, J., Bergthorsson, J. T., Arason, A., Agnarsson, B. A., Eiriksdottir, G., Johannsson, O. T., Borg, A., Ingvarsson, S., Easton, D. F., Egilsson, V., and Barkardottir, R. B. High prevalence of the 999del5 mutation in Icelandic breast and ovarian cancer patients. Cancer Res., 56: 3663-3665, 1996.
27. Thorlacius, S., Sigurdsson, S., Bjarnadottir, H., Olafsdottir, G., Jonasson, J. G., Tryggvadottir, L., Tulinius, H., and Eyfjord, J. E. Study of single BRCA2 mutation with high carrier frequency in a small population. Am. J. Hum. Genet., 60: 1079-1084, 1997.
28. Sigurdsson, S., Thorlacius, S., Tomasson, J., Tryggvadottir, L., Benediktsdottir, K., Eyfjord, J. E., and Jonsson, E. BRCA2 mutation in Icelandic prostate cancer patients. J. Mol. Med., 75: 758-761, 1997.
29. Durocher, F., Shattuck-Eidens, D., McClure, M., Labrie, F., Skolnick, M. H., Goldgar, D. E., and Simard, J. Comparison of BKCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breastyovarian cancer populations. Hum. Mol. Genet., 5: 835-842, 1996.
30. Friedman, L. S., Gayther, S. A., Kurosaki, T., Gordon, D., Noble, B., Casey, G., Ponder, B. A. J., and Anton-Culver, H. Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am. J. Hum. Genet., 60: 313-319, 1997.
31. Couch, F. J., Farid, L. M., DeShano, M. L., Tavtigian, S. V., Calzone, K., Campeau, L., Peng, Y., Bogden, B., Chen, Q., Neuhausen, S., Shattuck-Eidens, D., Godwin, A. K., Daly, M., Radford, D. M., Sedlacek, S., Rommens, J., Simard, J., Garber, J., Merajver, S., and Weber, B. L. BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat. Genet., 13: 123-125, 1996.
32. Takahashi, H., Chiu, H. C., Bandera, C. A., Behhakht, K., Liu, P. C., Couch, F. J., Weber, B. L., LiVolsi, V. A., Furusato, M., Rebane, B. A., Cardonick, A., Benjamin, I., Morgan, M. A., King, S. A., Mikula, J, J., Ruhin, S. C., and Boyd, J. Mutations of the BRCA2 gene in ovarian carcinomas. Cancer Res., 56: 2738-2741, 1996.
33. Fuks, F., Milner, J., and Kouzarides, T. BRCA2 associates with acetyltransferase activity when bound to P/CAF. Oncogene, 17: 2531-2534, 1998.
34. Puget, N., Stoppa-Lyonnet, D., Sinilnikova, O. M., Pages, S., Lynch, H. T., Lenoir, G. M., and Mazoyer, S. Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions. Cancer Res., 59: 455-461, 1999.
35. Haraldsson, K., Loman, N., Zhang, Q. X., Johannsson, O., Olsson, H., and Borg, A. BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease. Cancer Res., 58: 1367-1371, 1998.
36. Csokay, B., Udvarhelyi, N., Sulyok, Z., Besznyak, I., Ramus, S., Ponder, B., and Olah, E. High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history. Cancer Res., 59: 995-998, 1999.